Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer. Review uri icon

Overview

abstract

  • 5 year survival for childhood and adolescent cancer in developed countries is now in excess of 80% and the number of survivors of cancer continues to increase worldwide. After completion of therapy, many of these survivors will face a lifelong risk of endocrine late effects. We summarise the available evidence related to the prevalence and risk factors for endocrine late effects among adult survivors of childhood and adolescent cancer. Present screening, surveillance, and treatment recommendations differ by country and region, so we also highlight the continued effort to harmonise the international guidelines for this population.

publication date

  • April 12, 2015

Research

keywords

  • Endocrine System Diseases
  • Neoplasms

Identity

PubMed Central ID

  • PMC4490990

Scopus Document Identifier

  • 84934438306

Digital Object Identifier (DOI)

  • 10.1016/S2213-8587(15)00038-8

PubMed ID

  • 25873569

Additional Document Info

volume

  • 3

issue

  • 7